Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Therapies for Obstructive Sleep Apnea
NCT03189173Phase 2Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Sep 2017
- Primary completion
- May 2023
- Modality
- Inhalation Devices
- Countries
- 2
01
Overview
A Phase 2 trial of oxygen in obstructive sleep apnea (OSA), sponsored by Brigham and Women's Hospital. Started Sep 2017; status: completed.
02
Drugs
oxygen
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT03189173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03189173.